Exact Mass: 443.1692

Exact Mass Matches: 443.1692

Found 23 metabolites which its exact mass value is equals to given mass value 443.1692, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Thiothixene

(9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]-9H-thioxanthene-2-sulfonamide

C23H29N3O2S2 (443.1701)


Thiothixene is only found in individuals that have used or taken this drug. It is a thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics. [PubChem]Thiothixene acts as an antagonist (blocking agent) on different postsysnaptic receptors -on dopaminergic-receptors (subtypes D1, D2, D3 and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic-receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as an attenuation of extrapypramidal side-effects, but also leading to weight gain, fall in blood pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation, antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors (antisympathomimetic properties, lowering of blood pressure, reflex tachycardia, vertigo, sedation, hypersalivation and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism - controversial) and finally on muscarinic (cholinergic) M1/M2-receptors (causing anticholinergic symptoms like dry mouth, blurred vision, obstipation, difficulty/inability to urinate, sinus tachycardia, ECG-changes and loss of memory, but the anticholinergic action may attenuate extrapyramidal side-effects). D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent (Z)-Thiothixene is an antagonist of serotonergic receptor extracted from patent US 20150141345 A1.

   

8-AHA-cAMP

6-{6-amino-8-[(6-aminohexyl)amino]purin-9-yl}-2,7-dihydroxy-tetrahydro-4H-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one

C16H26N7O6P (443.1682)


   

8-Aminohexylamino cAMP

6-{6-amino-8-[(1-pentylhydrazin-1-yl)methyl]-9H-purin-9-yl}-2,7-dihydroxy-hexahydro-2lambda5-furo[3,2-d][1,3,2]dioxaphosphinin-2-one

C16H26N7O6P (443.1682)


   
   
   
   
   
   
   

Thiothixene

(e)-Thiothixene

C23H29N3O2S2 (443.1701)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AF - Thioxanthene derivatives C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent (Z)-Thiothixene is an antagonist of serotonergic receptor extracted from patent US 20150141345 A1.

   

7-Monodemethyl Minocycline

7-Monodemethyl Minocycline

C22H25N3O7 (443.1692)


   

8-(6-aminohexylamino) 3,5-cyclic AMP

8-(6-aminohexylamino) 3,5-cyclic AMP

C16H26N7O6P (443.1682)


   
   

Phe-Tyr-Asp

Phe-Tyr-Asp

C22H25N3O7 (443.1692)


A tripeptide composed of L-phenylalanine, L-tyrosine and L-aspartic acid joined by peptide linkages.

   
   
   
   
   
   

n-[4-({[2-(2,3-dihydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl](hydroxy)methylidene}amino)butyl]-2,3-dihydroxybenzenecarboximidic acid

n-[4-({[2-(2,3-dihydroxyphenyl)-5-methyl-4,5-dihydro-1,3-oxazol-4-yl](hydroxy)methylidene}amino)butyl]-2,3-dihydroxybenzenecarboximidic acid

C22H25N3O7 (443.1692)


   

(9s,12s,15s)-9-amino-4,10,13-trihydroxy-12-[(1s)-1-hydroxyethyl]-2-oxa-11,14-diazatricyclo[15.2.2.1³,⁷]docosa-1(19),3(22),4,6,10,13,17,20-octaene-15-carboxylic acid

(9s,12s,15s)-9-amino-4,10,13-trihydroxy-12-[(1s)-1-hydroxyethyl]-2-oxa-11,14-diazatricyclo[15.2.2.1³,⁷]docosa-1(19),3(22),4,6,10,13,17,20-octaene-15-carboxylic acid

C22H25N3O7 (443.1692)


   

(2s,3'r,4's,6's,9'r)-3',4',9'-trihydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1h-1',7'-diazaspiro[indole-2,5'-tricyclo[7.3.0.0³,⁷]dodecane]-2',3,8'-trione

(2s,3'r,4's,6's,9'r)-3',4',9'-trihydroxy-6-methoxy-6'-(2-methylprop-1-en-1-yl)-1h-1',7'-diazaspiro[indole-2,5'-tricyclo[7.3.0.0³,⁷]dodecane]-2',3,8'-trione

C22H25N3O7 (443.1692)


   

(9s,12s,15s)-9-amino-4,10,13-trihydroxy-12-[(1r)-1-hydroxyethyl]-2-oxa-11,14-diazatricyclo[15.2.2.1³,⁷]docosa-1(19),3(22),4,6,10,13,17,20-octaene-15-carboxylic acid

(9s,12s,15s)-9-amino-4,10,13-trihydroxy-12-[(1r)-1-hydroxyethyl]-2-oxa-11,14-diazatricyclo[15.2.2.1³,⁷]docosa-1(19),3(22),4,6,10,13,17,20-octaene-15-carboxylic acid

C22H25N3O7 (443.1692)